High-Dose Furmonertinib Management of Advanced NSCLC Harboring an EGFR Exon 14 Missense Mutation: A Case Report and Literature Review

03 June 2026 : Case report China

Unusual or unexpected effect of treatment, Rare disease

Jing-Yao Luo^{BEF 1}, Jie Xiang^{BF 2}, Xian-liang Hong^{BF 1}, Zhengrong Wang^{A 2*}

DOI: 10.12659/AJCR.949630

Am J Case Rep 2026; 27:e949630

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Treatment timeline and clinical course.

Back to the Article